Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception

European Journal of Pharmacology

Volumn 303, Issue 1-2, 1996, Pages 91-100

  Buritova, Jaroslava ^a,b   Chapman, Victoria ^a   Honoré, Prisca ^a   Besson, Jean Marie ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

(+) HA966; c Fos; Carrageenan; Inflammatory pain; Niflumic acid; Rat; Spinal cord

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; CARRAGEENAN; GLYCINE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARTIAL AGONIST; PROSTAGLANDIN RECEPTOR; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029974935     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00074-X     Document Type: Article

References (78)

1. Andreeva, L. and H.P. Rang, 1993, Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro, Br. J. Pharmacol. 108, 185.
2. Barres, B.A., 1991, New role for glia, J. Neurosci. 11, 3685.
3. Bienvenu, J., P. Laurent, L.F. Perrin, B. Colin and J.P. Rebattu, 1985, Use of acute phase protein changes to assess the effects of a non-steroidal antiinflammatory drug (niflumic acid) on the inflammation process induced by limited plastic surgery. Int. J. Clin. Pharmacol. Res. 5, 269.
4. Besson, J.-M. and A. Chaouch, 1987, Peripheral and spinal mechanisms of nociception, Physiol. Rev. 67, 67.
5. Boyle, E., P.C. Freeman, A.C. Goudie, F.R. Mangan and M. Thomson, 1976. The role of copper in preventing gastrointestinal damage by acidic anti-inflammatory drugs, J. Pharm. Pharmacol. 28, 865.
6. Buritova, J., P. Honoré, V. Chapman and J.M. Besson, 1995a, Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat, Neurosci. Lett. 188, 175.
7. Buritova, J., P. Honoré, V. Chapman and J.M. Besson, 1995b, Carrageenan oedema and spinal c-Fos-LI neurons are reduced by piroxicam in the rat, NeuroReport 6, 1385.
8. Buritova, J., P. Honoré, V. Chapman and J.M. Besson, in press, Enhanced effects of co-administerd dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat, Pain.
9. Chapman, V. and A.H. Dickenson, 1992, The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn, Brain Res. 573, 321.
10. Chapman, V., P. Honoré, J. Buritova and J.-M. Besson, 1995a, Dual blocage of μ-opioid and NMDA receptors profoundly reduces spinal c-Fos expression evoked by prolonged inflammatory pain, INRC St Andrews (Abstract).
11. Chapman, V., P. Honoré, J. Buritova and J.-M. Besson, 1995b, The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain, Br. J. Pharmacol. 116, 1628.
12. Chapman, V., P. Honoré, J. Buritova and J.-M. Besson, 1995c, Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat, Neuroscience 67, 731.
13. Coderre, T.J. and R. Melzack, 1992, The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury, J. Neurosci. 12, 3671.
14. 2 is noradrenergic terminal-dependent, Neurosci. Lett. 115, 253.
15. Dickenson, A.H., 1994, NMDA receptor antagonists as analgesics, in: Progress in Pain Research and Management, eds. H.L. Fields and J.C. Liebeskind (IASP, Seattle) p. 173.
16. Dickenson, A.H. and E. Aydar, 1991, Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat, Neurosci. Lett. 121, 263.
17. Dickenson, A.H. and A.F. Sullivan, 1990, Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat, Brain Res. 506, 31.
18. Dömötör, E., 1979, Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis, Ther. Hung. 27, 129.
19. Dumuis, A., M. Sebben, L. Haynes, J.-P. Pin and J. Bockaert, 1988, NMDA receptors activate the arachidonic acid cascade system in striatal neurons, Nature 336, 68.
20. Eisenberg, E., S. LaCross and A.M. Strassman, 1994, The effects of clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats, Eur. J. Pharmacol. 255, 123.
21. Flower, R., R. Gryglewski, K. Herbaczynska-Cedro and J.R. Vane, 1972, Effects of anti-inflammatory drugs on prostaglandin biosynthesis, Nature 238, 104.
22. Gulati, P.D., S. Lamba, S.N. Rizvi and H. Vaishnava, 1975, A double-blind cross-over study of niflumic acid and indomethacin in rheumathoid arthritis, J. Assoc. Physicians India 23, 897.
23. Haley, J.E., A.F. Sullivan and A.H. Dickenson, 1990, Evidence for the N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat, Brain Res. 518, 218.
24. Hargreaves, K., R. Dubner, F. Brown, C. Flores and J. Joris, 1988, A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain 32, 77.
25. Herdegen, T., K. Kovary, J. Leah and R. Bravo, 1991, Specific temporal and spatial distribution of JUN, FOS and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation, J. Comp. Neurol. 313, 178.
26. Hingtgen, C.M., K.J. Waite and M.R. Vasko, 1995, Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade, J. Neurosci. 15, 5411.
27. Honoré, P., J. Buritova and J.M. Besson, 1995a, Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin, Eur. J. Pharmacol. 272, 249.
28. Honoré, P., V. Chapman, J. Buritova and J.-M. Besson, 1995b, Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor, Br. J. Pharmacol. 114, 77.
29. Honoré, P., J. Buritova and J.-M. Besson, 1995c, Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation, Pain 663, 365.
30. Hsu, S., L. Raine and H. Fanger, 1981, Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures, J. Histochem. Cytochem. 29, 577.
31. Hughes, P. and M. Dragunow, 1995, Induction of immediate-early genes and the control of neurotransmitter-regulated expression within the nervous system, Pharmacol. Rev. 47, 133.
32. Hunter, J.C. and L. Singh, 1994, Role of excitatory amino acid receptors in the mediation of the nociceptive responses to formalin in the rat, Neurosci. Lett. 174, 217.
33. Iadarola, M.J., L.S. Brady, G. Draisci and R. Dubner, 1988, Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding, Pain 35, 313.
34. Insel, P.A., 1991, Analgesic-antipyretics and antiinflammatory agens; drugs employed in treatment of rheumatoid arthritis and gout, in: The Pharmacological Basis of Therapeutics, Vol. 8, eds. A. Goodman-Gilman et al. (McGraw-Hill, Singapore) p. 638.
35. Joris, J., A. Costello, R. Dubner and K. Hargreaves, 1990, Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia, Pain 43, 95.
36. Kayser, V. and G. Guilbaud, 1987, Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat, Pain 28, 99.
37. Kemp, J.A. and P.D. Leeson, 1993, The glycine site of NMDA receptor-five years on, Trends Pharmacol. 14, 20.
38. Kocher, L., F. Anton, P.W. Reeh and H.O. Handwerker, 1987, The effect of carrageenin-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat, Pain 29, 363.
39. Kristensen, J.D., R. Karlsten, T. Gordh and O.G. Berge, 1993, The NMDA antagonist 3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain 56, 51.
40. Laird, J.M.A., G.S. Mason, R.J. Hargreaves and R.G. Hill, 1994, Antagonists at the glycine modulatory site of the NMDA receptor complex reverse inflammatory-induced mechanical hyperalgesia in the rat, Am. Soc. Neurosci. 568.10 (Abstract).
41. Lerma, I. and R. Martin Del Rio, 1992, Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation, Mol. Pharmacol. 41, 217.
42. MacDermott, A.B., M.L. Mayer, G.L. Westbrook, S.J. Smith and J.L. Barker, 1986, NMDA-receptor activation increases cytoplasmatic calcium concentration in cultured spinal cord neurones, Nature 321, 519.
43. Malmberg, A.B. and T.L. Yaksh, 1992a, Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition, Science 257, 1276.
44. Malmberg, A.B. and T.L. Yaksh, 1992b, Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat, J. Pharmacol. Exp. Ther. 263, 136.
45. Malmberg, A.B. and T.L. Yaksh, 1994a, Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test in rats, Eur. J. Pharmacol. 256, 205.
46. Malmberg, A.B. and T.L. Yaksh, 1994b, Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test in rats, Neurosci. Lett. 173, 193.
47. 2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats, J. Neurosci. 15, 2768.
48. 2 and capsaicin on behavior and cerebrospinal fluid amino acid concentrations of unanesthetized rats: a microdialysis study, J. Neurochem.
49. Marriott, D., G.P. Wilkin, P.R. Coote and J.N. Wood, 1990, Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain, in: Advances in Prostaglandin, Tromboxane, and Leukotriene Research, eds. B. Samuelsson et al. (Raven, New York, NY) p. 739.
50. 2 binding sites in rat brain using quantitative autoradiography, Brain Res. 581, 292.
51. Menétrey, D., J. De Pommery, K.G. Baimbridge and M. Thomasset, 1992, Calbindin-D28K (CaBP28k)-like immunoreactivity in ascending projections. I. Trigemial nucleus caudalis and dorsal vagal complex projections, Eur. J. Neurosci. 4, 61.
52. Millan, M.J. and L. Seguin, 1993, (+ -HA966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice, Eur. J. Pharmacol. 238, 445.
53. Millan, M.J. and L. Seguin, 1994, Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice, Neurosci. Lett. 178, 139.
54. 2α injected into conscious mice, Pain 57, 225.
55. 2α in conscious mice, Pain 61, 285.
56. Molander, C. and G. Grant, 1986, Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horseradish peroxidase in the rat, Neuroscience 19, 297.
57. 2 increases calcium conductance and stimulates release of substance P in avian sensory neurons, J. Neurosci. 12, 1917.
58. Noguchi, K., K. Kowalski, R. Traub, A. Solodkin, M.J. Iadarola and M.A. Ruda, 1991, Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons, Mol. Brain Res. 10, 227.
59. Noguchi, K., R. Dubner and M.A. Ruda, 1992, Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins, Neuroscience 46, 561.
60. Pellerin, L. and S. Wolfe, 1991, Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus, Neurochem. Res. 16, 983.
61. Price, D.D., J. Mao, H. Frenk and D.J. Mayer, 1994, The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man, Pain 59, 165.
62. Ramwell, P.W., J.E. Shaw and R. Jessup, 1966, Spontaneous and evoked release of prostaglandins from frog spinal cord, Am. J. Physiol. 211, 998.
63. Ren, K. and R. Dubner, 1993, NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw, Neurosci. Lett. 163, 22.
64. Ren, K., J.K.L. Hylden, G.M. Williams, M.A. Ruda and R. Dubner, 1992a, The effects of non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation, Pain 50, 331.
65. Ren, K., G.M. Williams, J.K.L. Hylden, M.A. Ruda and R. Dubner, 1992b, The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenin-induced behavioral hyperalgesia in rats, Eur. J. Pharmocol. 219, 235.
66. Singh, L., A.E. Donald, A.C. Foster, P.H. Hutson, L.L. Iversen, S.D. Iversen, J.A. Kemp, P.D. Leeson, G.R. Marshall, R.J. Oles, T. Priestley, L. Thorn, M.D. Tricklebank, C.A. Vass and B.J. Williams, 1990, Enantiometers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is potent butyrolactone-like sedative, Proc. Natl. Acad. Sci. USA 87, 347.
67. 2, Anesthesiology 79, A909.
68. Tilve, G.H., J.K. Lengade, A.V. Bavadekar and K.G. Nair, 1976, Niflumic acid in the management of rheumatoid and osteoarthritis, J. Postgrad. Med. 22, 124.
69. Vaccarino, A.L., P. Marek, B. Kest, E. Weber, J.F.W. Keana and J.C. Liebeskind, 1993, NMDA receptor antagonist, MK-801 and ACE-1011, prevent the development of tonic pain following subcutaneuos formalin, Brain Res. 615, 331.
70. Vasko, M.R., S.L. Zirkelbach and K.J. Waite, 1993, Prostaglandins stimulate the release of substance P from rat spinal cord slices, Progr. Pharmacol. Clin. Pharmacol. 10, 69.
71. Willis, W.D. and R.E. Coggeshall, 1991, Sensory Mechanisms of the Spinal Cord (Plenum, New York, NY) p. 79.
72. Winter, C.A., E.A. Risley and G.W. Nuss, 1962, Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Proc. Soc. Exp. Biol. Med. 111, 544.
73. Wolfe, J.A., R. Poltzker, F.J. Safira, M. Ross, G. Popky and W. Rubin, 1976, Gastritis, duodenitis and bleeding duedenal ulcer following mefenamic acid therapy, Arch. Intern. Med. 136, 923.
74. Woolf, C.J. and S.W.N. Thompson, 1991, The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain 44, 293.
75. Xu, X.J., C.J. Dalsgaard and Z. Wiesenfeld-Hallin, 1992, Spinal substance P and NMDA receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex, Neuroscience 51, 641.
76. Yamamoto, T. and T.L. Yaksh, 1992, Comparison of the antinociceptive effects of pre- and post-treatment with morphine and MK-801, an NMDA antagonist, on the formalin test in the rat, Anesthesiology 77, 757.
77. Yamamoto, T., N. Shimoyama and T. Mizuguchi, 1993, The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK1 antagonist, on the hyperesthesia evoked by carrageenan injection in the rat paw, Anesthesiology 78, 124.
78. Zimmermann, M., 1983, Ethical guidelines for investigations of experimental pain in conscious animals, Pain 16, 109.